Growth Metrics

TransMedics (TMDX) Gross Margin (2018 - 2025)

Historic Gross Margin for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 58.8%.

  • TransMedics' Gross Margin rose 28600.0% to 58.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 60.28%, marking a year-over-year increase of 9400.0%. This contributed to the annual value of 59.36% for FY2024, which is 44200.0% down from last year.
  • Per TransMedics' latest filing, its Gross Margin stood at 58.8% for Q3 2025, which was up 28600.0% from 61.38% recorded in Q2 2025.
  • TransMedics' 5-year Gross Margin high stood at 81.76% for Q4 2021, and its period low was 55.94% during Q3 2024.
  • In the last 5 years, TransMedics' Gross Margin had a median value of 63.0% in 2021 and averaged 65.29%.
  • Per our database at Business Quant, TransMedics' Gross Margin surged by 184500bps in 2021 and then crashed by -157700bps in 2022.
  • Over the past 5 years, TransMedics' Gross Margin (Quarter) stood at 81.76% in 2021, then dropped by -19bps to 65.99% in 2022, then decreased by -11bps to 59.04% in 2023, then rose by 0bps to 59.21% in 2024, then dropped by -1bps to 58.8% in 2025.
  • Its Gross Margin stands at 58.8% for Q3 2025, versus 61.38% for Q2 2025 and 61.47% for Q1 2025.